Below are the most recent publications written about "Enoxaparin" by people in Profiles.
-
Palmieri A, Hicks V, Aikman N, Borowsky M, Haggerty A, ElSahwi K. Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer. South Med J. 2023 Oct; 116(10):790-794.
-
DeMik DE, Mont MA, Dunbar M. Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty. JAMA. 2023 01 10; 329(2):177.
-
Perrotti G, Sadri L, Fassler M, Sharma D, Kim S, Zebley M, Fassler S. One Size Does Not Fit All: Venous Thromboembolism Prophylaxis in Colorectal Cancer. JSLS. 2020 Jul-Sep; 24(3).
-
Imran JB, Madni TD, Clark AT, Rizk P, Huang E, Minshall CT, Taveras LR, Cunningham HB, Eastman AL, Koshy JP, Kacir CD, Cripps MW. Inability to predict subprophylactic anti-factor Xa levels in trauma patients receiving early low-molecular-weight heparin. J Trauma Acute Care Surg. 2018 11; 85(5):867-872.
-
Groff H, Azboy I, Parvizi J. Differences in Reported Outcomes in Industry-Funded vs Nonfunded Studies Assessing Thromboprophylaxis After Total Joint Arthroplasty. J Arthroplasty. 2018 11; 33(11):3398-3401.
-
Kerr NA, de Rivero Vaccari JP, Abbassi S, Kaur H, Zambrano R, Wu S, Dietrich WD, Keane RW. Traumatic Brain Injury-Induced Acute Lung Injury: Evidence for Activation and Inhibition of a Neural-Respiratory-Inflammasome Axis. J Neurotrauma. 2018 09 01; 35(17):2067-2076.
-
Fraint E, Miller R, Walter A. Posterior Reversible Encephalopathy Syndrome and Cerebral Sinus Thrombosis in a Case of Pediatric B-Cell ALL. J Pediatr Hematol Oncol. 2017 03; 39(2):e71-e73.
-
Ghaffarian K, Furin M, Bassett R. STEMI in a young female? Consider spontaneous peripartum coronary artery dissection. Am J Emerg Med. 2017 Feb; 35(2):381.e1-381.e4.
-
Goette A, Merino JL, Ezekowitz MD, Zamoryakhin D, Melino M, Jin J, Mercuri MF, Grosso MA, Fernandez V, Al-Saady N, Pelekh N, Merkely B, Zenin S, Kushnir M, Spinar J, Batushkin V, de Groot JR, Lip GY. Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. Lancet. 2016 Oct 22; 388(10055):1995-2003.
-
Streiff MB, Holmstrom B, Ashrani A, Bockenstedt PL, Chesney C, Eby C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Hendrie P, Kuderer N, Lee A, Lee JT, Lovrincevic M, Millenson MM, Neff AT, Ortel TL, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Yee GC, Zakarija A, McMillian N, Engh AM. Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. J Natl Compr Canc Netw. 2015 Sep; 13(9):1079-95.